LSIPR Article - Pharma patents: Growing pains for second medical use inventions
27 October 2015
Stephen Smith writes for the Life Sciences Intellectual Property Review.
UK court decisions in Warner-Lambert v Actavis seek to define second medical use patent rights, and how the recent full trial ruling provides us with some early guidance on the ‘reasonable foreseeability’ test concerning patent use.
To read the full article, please click here